Alexion Pharmaceuticals
ALXN
$182.50
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Revenue for Alexion Pharmaceuticals (ALXN)
Revenue in 2021 (TTM): $6.26 B
According to Alexion Pharmaceuticals's latest financial reports the company's current revenue (TTM) is $6.26 B. In 2020 the company made a revenue of $6.06 B an increase over the years 2019 revenue that were of $4.99 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Alexion Pharmaceuticals from 2001 to 2021
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2021 (TTM) | $6.26 B | 3.15% |
| 2020 | $6.06 B | 21.63% |
| 2019 | $4.99 B | 20.82% |
| 2018 | $4.13 B | 16.36% |
| 2017 | $3.54 B | 15.17% |
| 2016 | $3.08 B | 18.42% |
| 2015 | $2.60 B | 16.51% |
| 2014 | $2.23 B | 43.99% |
| 2013 | $1.55 B | 36.79% |
| 2012 | $1.13 B | 44.76% |
| 2011 | $0.78 B | 44.82% |
| 2010 | $0.54 B | 39.85% |
| 2009 | $0.38 B | 49.29% |
| 2008 | $0.25 B | 259.66% |
| 2007 | $72.04 M | 4523.88% |
| 2006 | $1.55 M | 13.14% |
| 2005 | $1.37 M | -70.12% |
| 2004 | $4.6 M | 557.49% |
| 2003 | $0.7 M | -85.98% |
| 2002 | $4.99 M | -50.6% |
| 2001 | $10.11 M |